Silverarc Capital Management’s Innate Pharma IPHA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-184,046
Closed -$839K 71
2021
Q4
$839K Buy
+184,046
New +$839K 0.34% 61